Skip to main content

Table 2 Incidence of hypomagnesemia and hypocalcemia after treatment with cetuximab or panitumumab

From: Correlation between blood magnesium and calcium concentration in patients treated with an anti-EGFR antibody

  Hypomagnesemia
N (%)
Hypocalcemia
N (%)
Any Grade 13 (59.1) 16 (72.7)
Grade 2 4 (18.2) 1 (4.5)
Grade 3/4 2 (9.1) 0 (0.0)